Cargando…
Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729141/ https://www.ncbi.nlm.nih.gov/pubmed/33311438 http://dx.doi.org/10.1038/s41392-020-00417-y |
_version_ | 1783621394021482496 |
---|---|
author | Loucera, Carlos Esteban-Medina, Marina Rian, Kinza Falco, Matías M. Dopazo, Joaquín Peña-Chilet, María |
author_facet | Loucera, Carlos Esteban-Medina, Marina Rian, Kinza Falco, Matías M. Dopazo, Joaquín Peña-Chilet, María |
author_sort | Loucera, Carlos |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7729141 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-77291412020-12-11 Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection Loucera, Carlos Esteban-Medina, Marina Rian, Kinza Falco, Matías M. Dopazo, Joaquín Peña-Chilet, María Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-12-11 /pmc/articles/PMC7729141/ /pubmed/33311438 http://dx.doi.org/10.1038/s41392-020-00417-y Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Letter Loucera, Carlos Esteban-Medina, Marina Rian, Kinza Falco, Matías M. Dopazo, Joaquín Peña-Chilet, María Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection |
title | Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection |
title_full | Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection |
title_fullStr | Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection |
title_full_unstemmed | Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection |
title_short | Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection |
title_sort | drug repurposing for covid-19 using machine learning and mechanistic models of signal transduction circuits related to sars-cov-2 infection |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729141/ https://www.ncbi.nlm.nih.gov/pubmed/33311438 http://dx.doi.org/10.1038/s41392-020-00417-y |
work_keys_str_mv | AT louceracarlos drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection AT estebanmedinamarina drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection AT riankinza drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection AT falcomatiasm drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection AT dopazojoaquin drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection AT penachiletmaria drugrepurposingforcovid19usingmachinelearningandmechanisticmodelsofsignaltransductioncircuitsrelatedtosarscov2infection |